Advance Purchase Agreement

A Contract Award Notice
by BUSINESS ENERGY AND INDUSTRIAL STRATEGY

Source
Contracts Finder
Type
Contract (Products)
Duration
15.5 month
Value
£1
Sector
HEALTH
Published
20 Oct 2021
Delivery
20 Sep 2021 to 31 Dec 2022
Deadline
19 Sep 2021 23:59

Concepts

Location

Geochart for 1 buyers and 2 suppliers

1 buyer

2 suppliers

Description

Procurement of the Covid-19 Adjuvanted Pandemic Vaccine.

Award Detail

1 Aventis Pharma (Reading)
  • Value: £1
2 Glaxosmithkline Biologicals (Rixensart)
  • Value: £1

CPV Codes

  • 33651600 - Vaccines

Other Information

Contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market. Advance Purchase Agreement - [REDACTED].pdf

Reference

Domains